Kalaris Therapeutics Stock (NASDAQ:KLRS)
Previous Close
$9.78
52W Range
$2.14 - $12.90
50D Avg
$7.87
200D Avg
$5.00
Market Cap
$183.28M
Avg Vol (3M)
$141.11K
Beta
-0.09
Div Yield
-
KLRS Company Profile
Kalaris Therapeutics Inc operates as a pharmaceutical company. The Company specializes in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.